loadpatents
name:-0.036991834640503
name:-0.017440795898438
name:-0.0037400722503662
CUSACK; Stephen Patent Filings

CUSACK; Stephen

Patent Applications and Registrations

Patent applications and USPTO patent grants for CUSACK; Stephen.The latest application filed is for "method and device for respiratory monitoring".

Company Profile
2.16.35
  • CUSACK; Stephen - Cork IE
  • CUSACK; Stephen - Seyssinet-Pariset FR
  • CUSACK; Stephen - Seyssinet FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Method And Device For Respiratory Monitoring
App 20220142504 - MURRAY; Myles ;   et al.
2022-05-12
Method and device for respiratory monitoring
Grant 11,259,716 - Murray , et al. March 1, 2
2022-03-01
Viral Polypeptide Fragments That Bind Cellular POL II C-Terminal Domain (CTD) and Their Uses
App 20190252037 - CUSACK; Stephen ;   et al.
2019-08-15
Influenza A 2009 Pandemic H1n1 Polypeptide Fragments Comprising Endonuclease Activity And Their Use
App 20180044649 - CUSACK; Stephen ;   et al.
2018-02-15
Polypeptide fragments comprising endonuclease activity and their use
Grant 9,890,368 - Bouvier , et al. February 13, 2
2018-02-13
Polypeptide Fragments Comprising Endonuclease Activity And Their Use
App 20180010109 - BOUVIER; Denis ;   et al.
2018-01-11
Cap/endo dual inhibitors and their use in the treatment, amelioration or prevention of a viral disease
Grant 9,827,244 - Schulz-Gasch , et al. November 28, 2
2017-11-28
Naphthyridinone derivatives and their use in the treatment, amelioration or prevention of a viral disease
App 20170290834 - WOLKERSTORFER; Andrea ;   et al.
2017-10-12
Influenza A 2009 pandemic H1N1 polypeptide fragments comprising endonuclease activity and their use
Grant 9,783,794 - Cusack , et al. October 10, 2
2017-10-10
Pyrrolopyrazine Derivatives For Use In The Treatment, Amelioration Or Prevention Of Influenza
App 20170100396 - SCHULZ-GASCH; Tanja ;   et al.
2017-04-13
Triazolones derivatives and their use in the treatment, amelioration or prevention of a viral disease
App 20170081324 - BUSCHMANN; Helmut ;   et al.
2017-03-23
Triazolones derivatives for use in the treatment, amelioration or prevention of a viral disease
App 20170081323 - BUSCHMANN; Helmut ;   et al.
2017-03-23
Pyrazolopyrazines and their use in the treatment, amelioration or prevention of a viral disease
App 20170081331 - BUSCHMANN; Helmut ;   et al.
2017-03-23
Cap/endo dual inhibitors and their use in the treatment, amelioration or prevention of a viral disease
App 20170000788 - Schulz-Gasch; Tanja ;   et al.
2017-01-05
Pyrimidin-4-one derivatives and their use in the tratement, amelioration or prevention of a viral disease
App 20160376286 - CLASSEN-HOUBEN; Dirk ;   et al.
2016-12-29
Heterocyclic Pyrimidine Carbonic Acid Derivatives Which Are Useful In The Treatment, Amelioration Or Prevention Of A Viral Disease
App 20160367557 - WOLKERSTORFER; Andrea ;   et al.
2016-12-22
7-oxo-thiazolopyridine Carbonic Acid Derivatives And Their Use In The Treatment, Amelioration Or Prevention Of A Viral Disease
App 20160362423 - WOLKERSTORFER; Andrea ;   et al.
2016-12-15
Substituted 1,5-naphthyridines as endonuclease inhibitors
Grant 9,505,758 - Wolkerstorfer , et al. November 29, 2
2016-11-29
Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease
App 20160297763 - CLASSEN-HOUBEN; Dirk ;   et al.
2016-10-13
7-oxo-thiazolopyridine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease
Grant 9,434,745 - Wolkerstorfer , et al. September 6, 2
2016-09-06
Cap/endo dual inhibitors and their use in the treatment, amelioration or prevention of a viral disease
Grant 9,359,351 - Schulz-Gasch , et al. June 7, 2
2016-06-07
Influenza A 2009 Pandemic H1n1 Polypeptide Fragments Comprising Endonuclease Activity And Their Use
App 20160053241 - Cusack; Stephen ;   et al.
2016-02-25
Naphthyridinone Derivatives And Their Use In The Treatment, Amelioration Or Prevention Of A Viral Disease
App 20160039818 - Wolkerstorfer; Andrea ;   et al.
2016-02-11
Pyridopyrazine Compounds And Their Use In The Treatment, Amelioration Or Prevention Of Influenza
App 20160002226 - Schulz-Gasch; Tanja ;   et al.
2016-01-07
Cap/endo Dual Inhibitors And Their Use In The Treatment, Amelioration Or Prevention Of A Viral Disease
App 20160002227 - Schulz-Gasch; Tanja ;   et al.
2016-01-07
A Method And Device For Respiratory Monitoring
App 20160000376 - MURRAY; Myles ;   et al.
2016-01-07
Substituted naphthyridines for the treatment, amelioration or prevention of a viral disease
Grant 9,199,987 - Wolkerstorfer , et al. December 1, 2
2015-12-01
Influenza A 2009 pandemic H1N1 polypeptide fragments comprising endonuclease activity and their use
Grant 9,181,307 - Cusack , et al. November 10, 2
2015-11-10
Pyrimidone derivatives and their use in the treatment, amelioration or prevention of a viral disease
Grant 9,045,486 - Wolkerstorfer , et al. June 2, 2
2015-06-02
Soluble fragments of influenza virus PB2 protein capable of binding RNA-cap
Grant 9,045,248 - Cusack , et al. June 2, 2
2015-06-02
Polypeptide Fragments Comprising Endonuclease Activity and Their Use
App 20150105315 - Bouvier; Denis ;   et al.
2015-04-16
Pyridone derivatives and their use in the treatment, ameloriation or prevention of a viral disease
Grant 8,952,039 - Wolkerstorfer , et al. February 10, 2
2015-02-10
Dihydroxypyrimidine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease
Grant 8,921,388 - Buschmann , et al. December 30, 2
2014-12-30
Pyridone Derivatives And Their Use In The Treatment, Ameloriation Or Prevention Of A Viral Disease
App 20140194476 - Wolkerstorfer; Andrea ;   et al.
2014-07-10
Pyrimidone Derivatives And Their Use In The Treatment, Amelioration Or Prevention Of A Viral Disease
App 20140194431 - Wolkerstorfer; Andrea ;   et al.
2014-07-10
Naphthyridinone Derivatives And Their Use In The Treatment, Amelioration Or Prevention Of A Viral Disease
App 20140194432 - Wolkerstorfer; Andrea ;   et al.
2014-07-10
Dihydroxypyrimidine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease
App 20140038990 - BUSCHMANN; Helmut ;   et al.
2014-02-06
Heterocyclic Pyrimidine Carbonic Acid Derivatives Which Are Useful In The Treatment, Amelioration Or Prevention Of A Viral Disease
App 20130317021 - WOLKERSTORFER; Andrea ;   et al.
2013-11-28
7-oxo-thiazolopyridine Carbonic Acid Derivatives And Their Use In The Treatment, Amelioration Or Prevention Of A Viral Disease
App 20130317022 - WOLKERSTORFER; Andrea ;   et al.
2013-11-28
Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease
App 20130102600 - CLASSEN-HOUBEN; Dirk ;   et al.
2013-04-25
Pyrimidin-4-one derivatives and their use in the treatment, amelioration or prevention of a viral disease
App 20130102601 - CLASSEN-HOUBEN; Dirk ;   et al.
2013-04-25
Influenza A 2009 Pandemic H1n1 Polypeptide Fragments Comprising Endonuclease Activity And Their Use
App 20130023565 - Cusack; Stephen ;   et al.
2013-01-24
Polypeptide Fragments Comprising Endonuclease Activity and Their Use
App 20120108493 - Bouvier; Denis ;   et al.
2012-05-03
Soluble Fragments Of Influenza Virus Pb2 Protein Capable Of Binding Rna-cap
App 20110008348 - Cusack; Stephen ;   et al.
2011-01-13
Modified adenoviral fibre and uses thereof
Grant 6,740,511 - Van Raaij , et al. May 25, 2
2004-05-25
Modified adenoviral fiber and uses
App 20040038205 - Van Raaij, Mark Johan ;   et al.
2004-02-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed